All In MedTech

Device Trial Radar · NCT02221934

Electrical Nerve Block for Amputation Pain

High-Frequency Nerve Block for Post-Amputation Pain: A Pivotal Study

Last checked: Nov 21, 2026Latest source record: Jun 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownResults posted on the registryPivotal-lookingTitle says "pivotal". Randomized with 607 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

607

Actual

Start

Oct 9, 2014

Primary completion

Dec 31, 2021

Study completion Sep 1, 2025

Sponsor

Lead sponsor
Neuros Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 21, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the clinical trial is to learn whether electrical nerve block via the Altius System is a safe and effective treatment for patients with post-amputation pain.

Conditions

  • Post-Amputation Pain
  • Phantom Limb Pain
  • Residual Limb Pain
  • Stump Pain

Interventions

  • AltiusDevice

    Electrical signal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Effectiveness Endpoint: Reduction of Pain Level by 50% From BaselineTime frame: Randomized Testing Window (Month-1 to Month-3 post implant, 2 Month duration)

1 more outcomes with a free account

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Pain Institute

    Scottsdale, Arizona

21 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.